Published in J Immunol on June 01, 2001
Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA (2011) 7.10
MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med (2007) 5.48
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis (2013) 5.00
Cell death. N Engl J Med (2009) 4.75
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol (2013) 4.38
Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med (2013) 3.25
Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med (2008) 2.93
Abandon the mouse research ship? Not just yet! Shock (2014) 2.60
The pathogenesis of sepsis. Annu Rev Pathol (2011) 2.55
Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol (2011) 2.38
IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol (2010) 2.29
Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice. J Leukoc Biol (2009) 2.27
Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg (2012) 2.24
Lethal pulmonary infection with Francisella novicida is associated with severe sepsis. J Leukoc Biol (2009) 2.01
The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood (2010) 1.97
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One (2009) 1.97
Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood (2008) 1.94
Mechanisms of mortality in early and late sepsis. Infect Immun (2006) 1.88
The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med (2008) 1.86
Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways. Proc Natl Acad Sci U S A (2006) 1.82
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care (2011) 1.78
Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun (2010) 1.76
Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. Am J Respir Crit Care Med (2006) 1.73
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care (2010) 1.73
Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci U S A (2003) 1.71
Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol (2008) 1.59
Rationale and design of the pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. JPEN J Parenter Enteral Nutr (2009) 1.58
Reactivation of multiple viruses in patients with sepsis. PLoS One (2014) 1.51
Biomarkers of sepsis. Crit Rev Clin Lab Sci (2013) 1.48
Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am (2008) 1.47
Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation. J Leukoc Biol (2012) 1.47
Cytokines, leptin, and stress-induced thymic atrophy. J Leukoc Biol (2008) 1.47
Milk fat globule epidermal growth factor 8 attenuates acute lung injury in mice after intestinal ischemia and reperfusion. Am J Respir Crit Care Med (2009) 1.45
Modeling sepsis in the laboratory: merging sound science with animal well-being. Comp Med (2008) 1.42
Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock? Crit Care (2006) 1.41
Sepsis induces extensive autophagic vacuolization in hepatocytes: a clinical and laboratory-based study. Lab Invest (2009) 1.41
A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care (2012) 1.41
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs (2011) 1.39
Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics (2011) 1.38
Immunosuppression following surgical and traumatic injury. Surg Today (2010) 1.36
Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. J Clin Pathol (2004) 1.34
The harmful role of c5a on innate immunity in sepsis. J Innate Immun (2010) 1.31
The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med (2014) 1.30
Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect Immun (2005) 1.30
Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Crit Care (2006) 1.29
Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. Infect Immun (2010) 1.25
Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology (2011) 1.21
Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol (2008) 1.21
Downregulation of CD40 ligand response in monocytes from sepsis patients. Clin Vaccine Immunol (2008) 1.20
Pathophysiologic mechanisms in septic shock. Lab Invest (2013) 1.19
When apoptosis meets autophagy: deciding cell fate after trauma and sepsis. Trends Mol Med (2009) 1.17
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit Care (2011) 1.17
Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis. J Immunol (2012) 1.16
Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit Care (2009) 1.16
The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence (2013) 1.15
CD4-expressing cells are early mediators of the innate immune system during sepsis. Shock (2008) 1.15
Milk fat globule epidermal growth factor-factor VIII is down-regulated in sepsis via the lipopolysaccharide-CD14 pathway. J Immunol (2009) 1.12
Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J Infect Dis (2012) 1.10
Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study. Crit Care (2009) 1.07
Gammadelta T cells mitigate the organ injury and mortality of sepsis. J Leukoc Biol (2007) 1.07
Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum. J Clin Invest (2005) 1.06
Molecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"? J Biomed Sci (2011) 1.04
B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients. Crit Care (2013) 1.03
A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes (2014) 1.03
Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest (2016) 1.02
Cholinergic regulatory lymphocytes re-establish neuromodulation of innate immune responses in sepsis. J Immunol (2011) 1.02
IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis. J Exp Med (2010) 1.02
The role of natural killer cells in sepsis. J Biomed Biotechnol (2011) 1.02
Sepsis, apoptosis and complement. Biochem Pharmacol (2008) 1.01
Serial cytokine levels in patients with severe sepsis. Inflamm Res (2009) 1.00
Modulation of the Bcl-2 family blocks sepsis-induced depletion of dendritic cells and macrophages. Shock (2009) 1.00
Sepsis, complement and the dysregulated inflammatory response. J Cell Mol Med (2009) 1.00
Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis. PLoS One (2012) 0.99
Divergent adaptive and innate immunological responses are observed in humans following blunt trauma. BMC Immunol (2010) 0.97
Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis. Eur J Immunol (2010) 0.96
Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice. Biochem Biophys Res Commun (2009) 0.96
Differential efficacy of caspase inhibitors on apoptosis markers during sepsis in rats and implication for fractional inhibition requirements for therapeutics. J Exp Med (2004) 0.96
Lymphocytes, apoptosis and sepsis: making the jump from mice to humans. Crit Care (2009) 0.95
Sepsis-induced SOCS-3 expression is immunologically restricted to phagocytes. J Leukoc Biol (2003) 0.95
Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients. Ann Surg (2003) 0.94
Impact of sepsis on CD4 T cell immunity. J Leukoc Biol (2014) 0.94
Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol (2004) 0.94
Vaccination with an attenuated strain of Francisella novicida prevents T-cell depletion and protects mice infected with the wild-type strain from severe sepsis. Infect Immun (2009) 0.94
CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis. PLoS One (2009) 0.94
T cell pathways involving CTLA4 contribute to a model of acute lung injury. J Immunol (2010) 0.94
Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections. Emerg Infect Dis (2007) 0.93
T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression. Crit Rev Immunol (2013) 0.91
Sepsis: from bench to bedside. Clinics (Sao Paulo) (2008) 0.91
Revisiting caspases in sepsis. Cell Death Dis (2014) 0.91
Rapid induction of autoantibodies during ARDS and septic shock. J Transl Med (2010) 0.89
Caspases as therapeutic targets. J Cell Mol Med (2008) 0.89
The role of regulatory T cells in the pathogenesis of sepsis and its clinical implication. J Interferon Cytokine Res (2012) 0.89
Patients with sepsis exhibit increased mitochondrial respiratory capacity in peripheral blood immune cells. Crit Care (2013) 0.89
Upregulation of GRAIL is associated with impaired CD4 T cell proliferation in sepsis. J Immunol (2014) 0.88
VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis. Crit Care (2009) 0.88
Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study. Crit Care (2016) 0.88
A historical perspective on sepsis. Am J Pathol (2012) 0.88
Increased susceptibility to Candida infection following cecal ligation and puncture. Biochem Biophys Res Commun (2011) 0.88
Early alterations of B cells in patients with septic shock. Crit Care (2013) 0.88
Failed interleukin-6 signal transduction in murine sepsis: attenuation of hepatic glycoprotein 130 phosphorylation. Crit Care Med (2009) 0.88
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03
Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med (1999) 7.24
Anatomy of herpes simplex virus DNA. IX. Apparent exclusion of some parental DNA arrangements in the generation of intertypic (HSV-1 X HSV-2) recombinants. J Virol (1977) 5.98
Polymyxin and related peptide antibiotics. Annu Rev Biochem (1977) 4.53
Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology (1999) 4.49
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol (2000) 3.58
A meta-analysis of prospective trials comparing percutaneous and surgical tracheostomy in critically ill patients. Chest (2000) 3.42
Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A (1999) 3.35
Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak. J Infect Dis (1978) 3.00
Haloalkane dehalogenases: structure of a Rhodococcus enzyme. Biochemistry (1999) 2.97
Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med (1997) 2.97
Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol (1999) 2.92
A failed assay opened a new door in growth hormone research. Endocrinology (1992) 2.69
Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomach. Gastroenterology (1999) 2.63
Ultrapermeable, reverse-selective nanocomposite membranes. Science (2002) 2.47
Morphologic diversity in malignant melanomas. Am J Clin Pathol (1990) 2.39
Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA (1992) 2.19
Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol (1998) 2.17
Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (L1A1) gene fragment. J Clin Microbiol (1994) 2.15
Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med (1996) 2.08
Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A (1993) 2.08
Nitric oxide inhibits stress-induced endothelial cell apoptosis. Crit Care Med (1998) 2.02
Carcinosarcomas: current perspectives and an historical review of nosological concepts. Semin Diagn Pathol (1993) 2.00
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol (1995) 1.94
Alanine and glutamine synthesis and release from skeletal muscle. I. Glycolysis and amino acid release. J Biol Chem (1976) 1.87
Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technol Ther (2000) 1.85
Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit Care Med (2000) 1.85
Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis (2001) 1.83
Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol (1989) 1.83
Demonstration of exogenous genital reinfection with herpes simplex virus type 2 by restriction endonuclease fingerprinting of viral DNA. J Infect Dis (1979) 1.82
Genital angiomyofibroblastoma. Comparison with aggressive angiomyxoma and other myxoid neoplasms of skin and soft tissue. Am J Clin Pathol (1997) 1.81
The abdominal compartment syndrome: CT findings. AJR Am J Roentgenol (1999) 1.81
Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet (1978) 1.79
Extracranial head and neck schwannomas: a review of 8 years experience. Acta Otolaryngol (2002) 1.75
Effect of red light on coleoptile growth. Plant Physiol (1974) 1.74
Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock (1997) 1.71
Interstitial laser photocoagulation for the treatment of osteoid osteoma. J Bone Joint Surg Br (2000) 1.68
Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics (2000) 1.68
Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. Infect Immun (1997) 1.67
Pancreas cancer resection outcome in American University centers in 1989-1990. Cancer (1993) 1.66
Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. Crit Care Med (1996) 1.66
Metastatic malignant melanoma with "rhabdoid" features. Am J Clin Pathol (1994) 1.65
Chordoma in childhood and adolescence. A clinicopathologic analysis of 12 cases. Arch Pathol Lab Med (1993) 1.61
Malignant rhabdoid tumor of the vulva: is distinction from epithelioid sarcoma possible? A pathologic and immunohistochemical study. Am J Surg Pathol (1989) 1.61
Alanine and glutamine synthesis and release from skeletal muscle. II. The precursor role of amino acids in alanine and glutamine synthesis. J Biol Chem (1976) 1.59
Health effects of beach water pollution in Hong Kong. Epidemiol Infect (1990) 1.58
Lymphocyte apoptosis during early phase of Listeria infection in mice. Am J Pathol (1997) 1.55
Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis (2003) 1.54
Adenocarcinoma in the lung in patients with breast cancer. A prospective analysis of the discriminatory value of immunohistology. Am J Clin Pathol (1993) 1.53
The structure of herpes simplex virus DNA and its application to molecular epidemiology. Ann N Y Acad Sci (1980) 1.52
Processing effect on soybean storage proteins and their relationship with tofu quality. J Agric Food Chem (1999) 1.50
Association between heart rate variability recorded on postoperative day 1 and length of stay in abdominal aortic surgery patients. Crit Care Med (2001) 1.49
Role of CuZn superoxide dismutase in regulating lymphocyte apoptosis during sepsis. Crit Care Med (2000) 1.48
Molecular markers and their use in animal breeding. Vet J (2000) 1.48
Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: report of a case and review of the literature. Pediatr Dev Pathol (2002) 1.47
Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong. Thorax (2005) 1.46
Inhibition of NO synthesis in septic shock. Lancet (1992) 1.46
CD31 immunoreactivity in small round cell tumors. Appl Immunohistochem Mol Morphol (2000) 1.45
Cytochrome P450 polymorphisms are associated with reduced warfarin dose. Surgery (2000) 1.44
Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod Pathol (2000) 1.44
Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest (1997) 1.43
Dissociation of effects of insulin and contraction on glucose transport in rat epitrochlearis muscle. Am J Physiol (1985) 1.42
Pulmonary embolism as a consequence of applying sequential compression device on legs in a patient asymptomatic of deep vein thrombosis. Anesthesiology (2000) 1.41
Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol (1992) 1.41
Obstructive lung disease does not increase lung cancer mortality among female never-smokers in Hong Kong. Int J Tuberc Lung Dis (2012) 1.41
Malignant peripheral nerve sheath tumor. An immunohistochemical study of 62 cases. Am J Clin Pathol (1987) 1.40